Blood Pressure and Lipid Control Status in Japanese Hypertensive Patients

References

• Kannel WB. Fifty years of Framingham study contributions to understanding hypertension. J Hum Hypertens 2000; 14: 83–90
   PubMed Web of Science ®Google Scholar
• Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 1998; 352: 1801–1807
   PubMed Web of Science ®Google Scholar
• Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21: 707–716
   PubMed Web of Science ®Google Scholar
• PROGRESS Collaborative Study Group. Randomised trial of perindopril based blood pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033–1041
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Hansson L, Clement D, Elmfeldt D, Julius S, Rosenthal T, Waeber B, Wedel H. HOT Study Group. Benefit and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?. J Hypertens 2003; 21: 797–804
   PubMed Web of Science ®Google Scholar
• The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–2997
   PubMed Web of Science ®Google Scholar
• Japanese Society of Hypertension (JSH) Guidelines for the Management of Hypertension 2004. Hypertens Res 2006; 29: S1–S105
   PubMed Web of Science ®Google Scholar
• Okamura T, Tanaka H, Miyamatsu N, Hayakawa T, Kadowaki T, Kita Y, Nakamura Y, Okayama A. Ueshima H, for the NIPPON DATA80 Research Group. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 2007; 190: 216–223
   PubMed Web of Science ®Google Scholar
• Sack FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun CC, Davis BR. Braunwald E, for the Cholesterol and Recurrent Event Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001–1009
   PubMed Web of Science ®Google Scholar
• Downs JR, Clearfield M, Weis S, Whitmey E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W. Gotto AM, for the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 1998; 279: 1615–1622
   PubMed Web of Science ®Google Scholar
• Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranalka M, Yamamoto A, Mizuno K. Ohashi Y, for the MEGA Study Group. Primary prevention of cardiovascular disease with pravastation in Japan (MEGA study): a prospective randomized controlled trial. Lancet 2006; 368: 1155–1163
   PubMed Web of Science ®Google Scholar
• Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389
   PubMed Web of Science ®Google Scholar
• Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K. Itakura H, and the J-LIT Study Group. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia-primary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J 2002; 66: 1087–1095
   PubMed Web of Science ®Google Scholar
• Hata Y, Mabuchi H, Saito Y, Itakura H, Egusa G, Ito H, Teramoto T, Tsushima M, Tada N, Oikawa S, Yamada N, Yamashita S, Sakuma N, Sasaki J. Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults. J Atheroscler Thromb 2002; 9: 1–27
   PubMedGoogle Scholar
• Teramoto T, Kashiwagi A. Mabuchi H, for the J-LAP investigators. Status of lipid-lowering therapy prescribed based on recommendations in the 2002 report of the Japan Atherosclerosis Society guideline for diagnosis and treatment of hyperlipidemia in Japanese adults: A study of the Japan Lipid Assessment Program (J-LAP). Curr Ther Res Clin Exp 2005; 66: 80–95
   PubMed Web of Science ®Google Scholar
• Barrios V, Escobar C, Calderón A, Llisterri JL, Echarri R, Alegría E, Muñiz J, Matalí A. Blood pressure and lipid goal attainment in the hypertensive population in the primary care setting in Spain. J Clin Hypertens 2007; 9: 324–329
   PubMedGoogle Scholar
• Ferdinand KC, Kleinpeter MA. Management of hypertension and dyslipidemia. Curr Hypertens Rep 2006; 8: 489–496
   PubMed Web of Science ®Google Scholar
• Matsubara K, Yamamoto Y, Sonoyama K, Igawa G, Furuse M, Yatsuhashi T, Hamada T, Ogino K, Igawa O, Hisatome I, Shigemasa C. Current status of lipid management of hypertensive patients. Hypertens Res 2003; 26: 699–704
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Saitoh S, Takagi S, Ohnishi H, Ohhata J, Isobe T, Shimamoto K. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the national cholesterol education program-adult treatment panel III to Japanese men-the Tanno and Sobetsu study. Hypertens Res 2005; 28: 203–208
   PubMed Web of Science ®Google Scholar
• Ohta Y, Tsuchihashi T, Arakawa K, Onaka U, Ueno M. Prevalance and characteristics of Japanese hypertensive patients with metabolic syndrome. Hypertens Res 2007; 30: 1077–1082
   PubMed Web of Science ®Google Scholar
• Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H. Kita T, on behalf of the Research Group on Serum Lipid Level Survey 2000 in Japan. Serum lipid survey and its recent trend in the general Japanese population in 2000. J Atheroscler Thromb 2005; 12: 98–106
   PubMed Web of Science ®Google Scholar
• Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, William GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245–1250
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Yamamoto T, Okamura T, Kadowaki T, Hayaakawa T, Kita Y, Saitoh S, Okayama A. Ueshima H, for the NIPPON DATA 80 Research Group. Combined cardiovascular risk factors and outcome-NIPPON DATA 80, 1980–1994. Circ J 2006; 70: 960–964
   PubMed Web of Science ®Google Scholar
• Kannel WB. Risk stratification in hypertension: New insights from the Framingham study. Am J Hypertens 2000; 13: 3S–10S
   PubMed Web of Science ®Google Scholar
• Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, Kristinsson A, Mclnnes G, Mehlsen J, Nieminen M, O'Brien E. Ostergren J, for the ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomized controlled trial. Lancet 2003; 361: 1149–1158
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J. Itakura H, for the J-LIT Study Group. The risk of cardiovascular event in Japanese hypertensive patients with hypercholesterolemia: Sub-analysis of the Japan Lipid Intervention Trial (J-LIT) study, a large-scale observational cohort study. Hypertens Res 2005; 28: 879–887
   PubMed Web of Science ®Google Scholar
• Thomas F, Rudnichi A, Bacri AM, Bean K, Guize L. Benetos A: Cardiovascular mortality in hypertensive men according to presence of associated risk factors. Hypertension 2001; 37: 1256–1261
   PubMed Web of Science ®Google Scholar
• Massimo V, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E, Menotti A, Zanchetti A, Mancia G. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007; 25: 1491–1498
   PubMed Web of Science ®Google Scholar